First Eagle Investment Management LLC acquired a new position in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 212,500 shares of the company’s stock, valued at approximately $4,329,000. First Eagle Investment Management LLC owned about 0.13% of Envista at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its position in shares of Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after acquiring an additional 638 shares during the last quarter. Claret Asset Management Corp boosted its stake in Envista by 6.5% during the 2nd quarter. Claret Asset Management Corp now owns 11,827 shares of the company’s stock valued at $231,000 after purchasing an additional 724 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after purchasing an additional 949 shares during the last quarter. Farther Finance Advisors LLC increased its stake in shares of Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after purchasing an additional 1,026 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its holdings in shares of Envista by 5.9% during the third quarter. Vanguard Personalized Indexing Management LLC now owns 21,283 shares of the company’s stock valued at $434,000 after buying an additional 1,183 shares during the last quarter.
Insider Activity
In other Envista news, SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. This represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.66% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on Envista
Envista Price Performance
Shares of Envista stock opened at $28.43 on Thursday. Envista Holdings Corporation has a 52 week low of $14.22 and a 52 week high of $30.42. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. The stock has a market cap of $4.66 billion, a PE ratio of 101.54, a price-to-earnings-growth ratio of 1.96 and a beta of 0.95. The company’s 50-day moving average price is $25.57 and its two-hundred day moving average price is $22.33.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same period in the previous year, the company posted $0.24 EPS. Envista’s quarterly revenue was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, sell-side analysts anticipate that Envista Holdings Corporation will post 1 EPS for the current fiscal year.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
See Also
- Five stocks we like better than Envista
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
